489 related articles for article (PubMed ID: 31734711)
1. Nanoscale metal-organic frameworks as key players in the context of drug delivery: evolution toward theranostic platforms.
Carrillo-Carrión C
Anal Bioanal Chem; 2020 Jan; 412(1):37-54. PubMed ID: 31734711
[TBL] [Abstract][Full Text] [Related]
2. Recent Advances in Metal-Organic Frameworks as Anticancer Drug Delivery Systems: A Review.
Karami A; Mohamed O; Ahmed A; Husseini GA; Sabouni R
Anticancer Agents Med Chem; 2021; 21(18):2487-2504. PubMed ID: 33463479
[TBL] [Abstract][Full Text] [Related]
3. Metal-Organic Framework-Based Nanomedicine Platforms for Drug Delivery and Molecular Imaging.
Cai W; Chu CC; Liu G; Wáng YX
Small; 2015 Oct; 11(37):4806-22. PubMed ID: 26193176
[TBL] [Abstract][Full Text] [Related]
4. Metal-Organic Framework (MOF)-Based Drug/Cargo Delivery and Cancer Therapy.
Wu MX; Yang YW
Adv Mater; 2017 Jun; 29(23):. PubMed ID: 28370555
[TBL] [Abstract][Full Text] [Related]
5. Nanoporous metal organic frameworks as hybrid polymer-metal composites for drug delivery and biomedical applications.
Beg S; Rahman M; Jain A; Saini S; Midoux P; Pichon C; Ahmad FJ; Akhter S
Drug Discov Today; 2017 Apr; 22(4):625-637. PubMed ID: 27742533
[TBL] [Abstract][Full Text] [Related]
6. Bioengineering of Metal-organic Frameworks for Nanomedicine.
Liu Y; Zhao Y; Chen X
Theranostics; 2019; 9(11):3122-3133. PubMed ID: 31244945
[TBL] [Abstract][Full Text] [Related]
7. Stimuli-Responsive Design of Metal-Organic Frameworks for Cancer Theranostics: Current Challenges and Future Perspective.
Pantwalawalkar J; Mhettar P; Nangare S; Mali R; Ghule A; Patil P; Mohite S; More H; Jadhav N
ACS Biomater Sci Eng; 2023 Aug; 9(8):4497-4526. PubMed ID: 37526605
[TBL] [Abstract][Full Text] [Related]
8. Metal organic frameworks (MOFs) with therapeutic and biomedical applications: a patent review.
Teixeira de Alencar Filho JM; Sampaio PA; Silva de Carvalho I; Rocha da Silva A; Pereira ECV; Araujo E Amariz I; Nishimura RHV; Cavalcante da Cruz Araújo E; Rolim-Neto PJ; Rolim LA
Expert Opin Ther Pat; 2021 Oct; 31(10):937-949. PubMed ID: 33915072
[No Abstract] [Full Text] [Related]
9. Design of Metal-Organic Frameworks for pH-Responsive Drug Delivery Application.
Shen X; Pan Y; Sun Z; Liu D; Xu H; Yu Q; Trivedi M; Kumar A; Chen J; Liu J
Mini Rev Med Chem; 2019; 19(20):1644-1665. PubMed ID: 31880236
[TBL] [Abstract][Full Text] [Related]
10. Theranostics of metal-organic frameworks: image-guided nanomedicine for clinical translation.
Mehata AK; Vikas ; Viswanadh MK; Muthu MS
Nanomedicine (Lond); 2023 Apr; 18(8):695-703. PubMed ID: 37259854
[TBL] [Abstract][Full Text] [Related]
11. Current and emerging applications of nanostructured metal-organic frameworks in cancer-targeted theranostics.
Lakshmi BA; Kim S
Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110091. PubMed ID: 31546428
[TBL] [Abstract][Full Text] [Related]
12. Metal-Organic Framework (MOF)-based Nanomaterials for Biomedical Applications.
Luo Z; Fan S; Gu C; Liu W; Chen J; Li B; Liu J
Curr Med Chem; 2019; 26(18):3341-3369. PubMed ID: 29446726
[TBL] [Abstract][Full Text] [Related]
13. Constructing Redox-Responsive Metal-Organic Framework Nanocarriers for Anticancer Drug Delivery.
Lei B; Wang M; Jiang Z; Qi W; Su R; He Z
ACS Appl Mater Interfaces; 2018 May; 10(19):16698-16706. PubMed ID: 29692177
[TBL] [Abstract][Full Text] [Related]
14. Nanoscaled Metal-Organic Frameworks for Biosensing, Imaging, and Cancer Therapy.
Zhou J; Tian G; Zeng L; Song X; Bian XW
Adv Healthc Mater; 2018 May; 7(10):e1800022. PubMed ID: 29508557
[TBL] [Abstract][Full Text] [Related]
15. Metal-Organic Frameworks at the Biointerface: Synthetic Strategies and Applications.
Doonan C; Riccò R; Liang K; Bradshaw D; Falcaro P
Acc Chem Res; 2017 Jun; 50(6):1423-1432. PubMed ID: 28489346
[TBL] [Abstract][Full Text] [Related]
16. Progress of Stimuli-Responsive Nanoscale Metal Organic Frameworks as Controlled Drug Delivery Systems.
Feng A; Wang Y; Ding J; Xu R; Li X
Curr Drug Deliv; 2021; 18(3):297-311. PubMed ID: 32940178
[TBL] [Abstract][Full Text] [Related]
17. Recent progress in nanoscale metal-organic frameworks for drug release and cancer therapy.
He L; Liu Y; Lau J; Fan W; Li Q; Zhang C; Huang P; Chen X
Nanomedicine (Lond); 2019 May; 14(10):1343-1365. PubMed ID: 31084393
[TBL] [Abstract][Full Text] [Related]
18. Metal-Organic Framework-Templated Biomaterials: Recent Progress in Synthesis, Functionalization, and Applications.
Begum S; Hassan Z; Bräse S; Wöll C; Tsotsalas M
Acc Chem Res; 2019 Jun; 52(6):1598-1610. PubMed ID: 30977634
[TBL] [Abstract][Full Text] [Related]
19. Metal-Organic Framework Derived Nanozymes in Biomedicine.
Wang D; Jana D; Zhao Y
Acc Chem Res; 2020 Jul; 53(7):1389-1400. PubMed ID: 32597637
[TBL] [Abstract][Full Text] [Related]
20. Biomedical Applications of Metal-Organic Frameworks for Disease Diagnosis and Drug Delivery: A Review.
Al Sharabati M; Sabouni R; Husseini GA
Nanomaterials (Basel); 2022 Jan; 12(2):. PubMed ID: 35055294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
